ArticleActa obstetricia et gynecologica Scandinavica2025
Risk factors and risk-indicating model for early-onset neonatal sepsis after preterm prelabor rupture of membranes: A historical cohort study.
Article in Acta obstetricia et gynecologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk factors and risk-indicating model for early-onset neonatal sepsis after preterm prelabor rupture of membranes: A historical cohort study.Acta obstetricia et gynecologica Scandinavica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionEarly-onset neonatal sepsis (EONS) is an important cause of neonatal morbidity and mortality and is strongly associated with intra-amniotic infection. The risk of intra-amniotic infection increases after preterm prelabor rupture of membranes (PPROM). Better tools are needed for monitoring women with PPROM for intra-amniotic infection and identifying those at high risk of EONS so that intervention can be made timely. This study aimed to identify antepartum risk factors for EONS in a PPROM population and develop a risk-indicating model. MATERIAL AND
methodsWe performed a historical cohort study on PPROM pregnancies delivering between gestational weeks 24 + 0 and 33 + 6 in Stockholm, Sweden. Using logistic regression, we evaluated the risk of the outcome EONS associated with maternal background characteristics, symptoms and signs, and cardiotocography. We combined variables associated with high risk into a risk-indicating model and estimated its performance by calculating its sensitivity, specificity, accuracy, positive and negative predictive values, positive likelihood ratio, and area under the ROC curve.
resultsWe included 709 women and their neonates, out of which 29 developed EONS. Variables most strongly associated with EONS were maternal diabetes (OR 4.37, 95% CI 1.41-13.56), maternal temperature ≥ 38°C (OR 6.42, 95% CI 2.94-14.02), positive urinary or vaginal/cervical culture (OR 2.62, 95% CI 1.14-6.03), and cardiotocography parameters. Fetal baseline frequency above 160 bpm was associated with a 3.75 times increased risk of EONS (95% CI 1.51-9.33). Meanwhile, short-term variation was negatively associated with EONS risk, and a value below 4 ms had a 4.17 times increased risk of EONS (95% CI 1.77-9.83). A risk-indicating model for EONS combining the mentioned variables had an area under the ROC curve of 0.7348. This model performed better at indicating risk for EONS than the clinicians' suspicion of intra-amniotic infection.
conclusionsMaternal diabetes, maternal fever, positive urinary or vaginal/cervical culture, fetal tachycardia, and decreasing short-term variation were associated with an increased risk for EONS in a PPROM population. A risk-indicating model combining these risk factors performed better than the clinicians' suspicion of intra-amniotic infection in identifying high-risk pregnancies for EONS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.